| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/07/2004 | CN1511157A Novel pyrrole derivatives as pharmaceutical agents |
| 07/07/2004 | CN1511155A Amido ether substituted imidazoquinolines |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/07/2004 | CN1509727A Rose donkey-hide gelatin and its preparation |
| 07/07/2004 | CN1509725A Oral staphylococcus aureus filtrate preparation for improving immune function |
| 07/07/2004 | CN1156478C Substituted porphyrins |
| 07/07/2004 | CN1156471C 5-phridyl-1,3-azole compounds, process for producing the same and use thereof |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/07/2004 | CN1156282C 活性山羊血粉胶囊 Activity goat blood meal capsule |
| 07/06/2004 | US6759535 A 3-amide-methyl- or 3-urea-isoquinoline derivatives, enzyme inhibitor of protein kinase, for treating cell proliferation, cell death, inflammatory diseases, autoimmune diseases, bone disorders, infectious diseases, viral diseases |
| 07/06/2004 | US6759518 Single-chain multiple antigen-binding molecule, its preparation and use |
| 07/06/2004 | US6759422 Administering benzothiazole compound for therapy, prophylaxis of disease |
| 07/06/2004 | US6759420 Low molecular weight, factor xa specific blood clotting inhibitors without side effects |
| 07/06/2004 | US6759414 Aromatic amides |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | US6759407 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, ESP as parasiticides |
| 07/06/2004 | US6759042 Use of cross-linked, covalently bound urokinase plasminogen activator (scuPA)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent |
| 07/06/2004 | US6758840 Drug delivery device |
| 07/06/2004 | CA2312206C Novel bicyclic derivatives of amino-pyrazinones, process for preparing them and pharmaceutical compositions containing them |
| 07/06/2004 | CA2085201C New pyridyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/06/2004 | CA2060401C N-2-chlorobenzyl-2-oxo and n-2-chlorobenzyl-2, 2-dioxo-1,2,3-oxathiazolidine derivatives, their preparation and synthesis of thieno¬3,2-c|pyridine derivatives therefrom |
| 07/01/2004 | WO2004054620A1 Induction of tolerance through oral administration of a therapeutic agent coupled to a transporting agent |
| 07/01/2004 | WO2004054356A2 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 07/01/2004 | WO2004002420A3 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 07/01/2004 | WO2003100435A3 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2) |
| 07/01/2004 | WO2003093297A3 Protein kinase modulators and methods of use |
| 07/01/2004 | WO2003092605A3 Protease inhibitors |
| 07/01/2004 | WO2002100341A3 Compounds for the treatment of metabolic disorders |
| 07/01/2004 | US20040127712 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 07/01/2004 | US20040127707 Novel phthalazinones |
| 07/01/2004 | US20040127544 Mannich base prodrugs of 3-(Pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 07/01/2004 | US20040127542 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 07/01/2004 | US20040127537 Stable liquid parenteral parecoxib formulation |
| 07/01/2004 | US20040127528 Metalloproteinase inhibitors |
| 07/01/2004 | US20040127496 Imidazole-2-carboxamide derivatives as raf kinase inhibitors |
| 07/01/2004 | US20040127474 Contacting the cell with a ptc agonist in a sufficient amount to inhibit the altered growth state, wherein the ptc agonist is a organic molecule having a molecular weight less than about 750 amu for inhibiting an altered growth state of a cell |
| 07/01/2004 | US20040127468 phosphatidic acid decreases apoptosis induced by the sudden withdrawal of NGF and serum (trophic withdrawal), rotenone, and glutamate |
| 07/01/2004 | US20040127456 an antiendotoxin compound is administered (e.g., intravenously) to a patient, before, during, and/or after surgery |
| 07/01/2004 | US20040127438 polypeptide (or its encoding nucleic acid molecule from Mycobacterium tuberculosis or related prokaryotes in the treatment of cancer, allergic disorders or conditions of immunoactivation, particularly asthma |
| 07/01/2004 | US20040127410 Circular permuteins of flt3 ligand |
| 07/01/2004 | US20040126870 Ncc2705-the genome of a bifodobacterium |
| 07/01/2004 | US20040126799 First nucleotide sequence comprises adenine residue at position 1033 or equivalent; reducing disease treatment side effects |
| 07/01/2004 | US20040126759 Molecules for disease detection and treatment |
| 07/01/2004 | US20040126420 phosphatidylcholine, sphingomyelin, phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and cholesterol; for removal of extra-/intra- vascular fibrin clots/adhesions; for use during surgery; for treatment of otitis |
| 07/01/2004 | US20040126400 Delivery of therapeutic compounds via microparticles or microbubbles |
| 06/30/2004 | EP1433788A1 Pyrazole-derivatives as factor Xa inhibitors |
| 06/30/2004 | EP1433500A2 Blood fluidity-improving health foods |
| 06/30/2004 | EP1432991A1 Identification and isolation of somatic stem cells and uses thereof |
| 06/30/2004 | EP1432802A2 Pegylated and diglycosylated erythropoietin |
| 06/30/2004 | EP1432801A2 Receptors and membrane-associated proteins |
| 06/30/2004 | EP1432794A2 Human coagulation factor vii polypeptides |
| 06/30/2004 | EP1432732A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/30/2004 | EP1432718A1 Chemical compounds |
| 06/30/2004 | EP1432715A2 Pyrimidine derivatives |
| 06/30/2004 | EP1432700A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 06/30/2004 | EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 06/30/2004 | EP1432460A2 Bioactive materials for aneurysm repair |
| 06/30/2004 | EP1432454A2 Methods for sterilizing preparations containing albumin |
| 06/30/2004 | EP1432452A2 Inhibition of stat-1 |
| 06/30/2004 | EP1432438A2 Use of rank antagonists to treat cancer |
| 06/30/2004 | EP1432437A2 Human tissue urokinase type plasminogen activator formulation |
| 06/30/2004 | EP1432435A1 Enamel matrix protein compositions for modulating immune response |
| 06/30/2004 | EP1070049B1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
| 06/30/2004 | EP0971908B1 Il-8 receptor antagonists |
| 06/30/2004 | EP0726311B1 Process for preparing human activated protein c |
| 06/30/2004 | CN1509337A New polynucleotides and polypeptides of IFN alpha-17 gene |
| 06/30/2004 | CN1509286A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509283A Novel pyridyl cyanoguandine compounds |
| 06/30/2004 | CN1509276A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509274A Metallo proteinase inhibitors |
| 06/30/2004 | CN1509273A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509272A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509188A Immunoconjugates made of egg-yolk antibiodies (IGY), production and use thereof in diagnoses and therapy |
| 06/30/2004 | CN1507924A Preparation method for producing fibrin gel and platelect gel using human thromblase |
| 06/30/2004 | CN1507898A Nereid-containing health-care product for improving nutritional anemia |
| 06/30/2004 | CN1507891A Series medicament of zanthoxylum bungeanum seed kernel oil and pseudo-ginseng total saponin and preparing process thereof |
| 06/30/2004 | CN1507870A Medicinal composition for antipyretic, analgesic, anti-inflammatory and anti platelet aggregation |
| 06/30/2004 | CN1155608C Propargyl phenyl ether A2A receptor agonists |
| 06/30/2004 | CN1155600C 2,3-diaryl-pyrazolo[1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2(cox-2) inhibitors |
| 06/30/2004 | CN1155403C Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma |
| 06/30/2004 | CN1155384C Cyclodextrin encapsulated freeze-dried powder injection of prostaglandin E1 and production technology thereof |
| 06/29/2004 | US6756480 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/29/2004 | US6756403 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor |
| 06/29/2004 | US6756401 Drug mixtures comprising estrogen agonists or antagonists and anticholesterol statins, administered to promote bone formation, prevent bone disorders and/or as anticholesterol agents |
| 06/29/2004 | US6756393 Amides and ureas n-substituted with piperidine or nortropane; serotonin inverse agonists or antagonists; antipsychotic |
| 06/29/2004 | US6756382 Amide substituted imidazoquinolines |
| 06/29/2004 | US6756381 A purified antitumor agent is crystallized from acetone or dichloromethane |
| 06/29/2004 | US6756206 Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides |
| 06/29/2004 | US6756031 One or more of: polyacrylonitrile, polyvinylacetate, cellulose acetate butyrate, nitrocellulose and polycarbonateurethane copolymers and maleic acid-styrene copolymers; a contrast agent, and a biocompatible solvent |
| 06/29/2004 | US6755856 Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
| 06/29/2004 | CA2296726C Combination therapy |
| 06/24/2004 | WO2004052893A2 Substituted dihydropyrano indole-3,4-dione derivatives and 3-oxoacetic acid substituted 2-hydroxymethylindole derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | WO2004052871A1 Benzomorpholine derivatives |
| 06/24/2004 | WO2004052863A1 Anti-inflammatory agent |
| 06/24/2004 | WO2004052859A1 Erythropoietin production accelerator |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052385A1 Composition containing green and yellow vegetables and light-colored vegetables |
| 06/24/2004 | WO2004052366A1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 06/24/2004 | WO2004014304A3 Electrospun amorphous pharmaceutical compositions |
| 06/24/2004 | WO2003057200A3 Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes |